She has a background in both industry and corporate finance with 14 years of experience in SMEs in the biotech and hi-tech sectors and has held roles with Cytomyx Holdings plc, RioTech Pharmaceuticals Ltd, Hybrid Biosystems Ltd and Myotec Therapeutics Ltd. Prior to this, Theo trained with PricewaterhouseCoopers and read Classics at Trinity College, Cambridge.